Viemed Healthcare Inc (VMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Viemed Healthcare Inc (VMD) has a cash flow conversion efficiency ratio of 0.136x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($18.37 Million) by net assets ($135.50 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See VMD equity to assets ratio to measure how much of total assets are equity-financed.
Viemed Healthcare Inc - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Viemed Healthcare Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Viemed Healthcare Inc (VMD) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Viemed Healthcare Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Viemed Healthcare Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Swarmer, Inc Common Stock
NASDAQ:SWMR
|
N/A |
|
Hubei Guochuang Hi-tech Material Co Ltd
SHE:002377
|
-0.083x |
|
Voyager Acquisition Corp
NASDAQ:VACH
|
0.010x |
|
Aramis SAS
PA:ARAMI
|
0.246x |
|
HaiXin Foods Co Ltd
SHE:002702
|
0.122x |
|
Jiangsu Aoyang Technology Ltd
SHE:002172
|
0.171x |
|
Zhejiang Dibay Electric Co Ltd
SHG:603320
|
0.023x |
|
Borussia Dortmund GmbH & Co KGaA
XETRA:BVB
|
0.005x |
Annual Cash Flow Conversion Efficiency for Viemed Healthcare Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of Viemed Healthcare Inc from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see VMD market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $133.30 Million | $39.09 Million | 0.293x | -26.13% |
| 2023-12-31 | $113.89 Million | $45.21 Million | 0.397x | +38.90% |
| 2022-12-31 | $97.09 Million | $27.75 Million | 0.286x | +20.47% |
| 2021-12-31 | $94.82 Million | $22.49 Million | 0.237x | -44.80% |
| 2020-12-31 | $81.69 Million | $35.11 Million | 0.430x | -1.60% |
| 2019-12-31 | $43.70 Million | $19.09 Million | 0.437x | -31.59% |
| 2018-12-31 | $35.03 Million | $22.37 Million | 0.638x | +26.08% |
| 2017-12-31 | $23.74 Million | $12.02 Million | 0.506x | +1.69% |
| 2016-12-31 | $12.88 Million | $6.41 Million | 0.498x | -38.15% |
| 2015-12-31 | $11.65 Million | $9.38 Million | 0.805x | -10.57% |
| 2014-12-31 | $8.43 Million | $7.59 Million | 0.900x | -- |
About Viemed Healthcare Inc
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive … Read more